Stock News - MiNK Therapeutics, Inc. $INKT
Latest Stock News for $INKT
MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum
Expected Stock impact: Very Positive
2026-03-31 12:08:41
MiNK Therapeutics Provides Update on Potential Combination Trials for agenT-797
Expected Stock impact: Slightly Positive
2026-03-27 14:41:21
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers
Expected Stock impact: Slightly Positive
2026-03-20 15:12:37
